NCT02051023View on ClinicalTrials.gov

Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca)

PHASE3CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Dry Eye
Interventions
DRUG

FML 0.1% eyedrops

Ocular topical application of fluorometholone 0.1% 4 times a day during 22 days

DRUG

Liquifilm artificial tears eyedrops

Liquifilm instillation 4 times a day for 22 days

Trial Locations (2)

47011

IOBA (Instituto de Oftalmobiología Aplicada), University of Valladolid, Valladolid

IOBA, Valladolid

All Listed Sponsors
lead

Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA

OTHER

NCT02051023 - Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca) | Biotech Hunter | Biotech Hunter